readthroughSign in
CompanyHCMHMDCFNasdaq, OTCHong Kong

Hutchmed

Hutchmed discovers and develops targeted therapies and immunotherapies for cancer and immunological diseases.

10-QNov 16Latest SEC filing
Nov 5Latest story

November 2026

October 2026

September 2026

August 2026

July 2026

June 2026